Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 51, 2013, Pages 20605-20610

  Chen, Chen ^a   Zhang, Liguo ^a   Huang, Nai Jia ^a   Huang, Bofu ^a   Kornbluth, Sally ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

H2AX; DsDNA IP; PMA; SL0101

Indexed keywords

ATM PROTEIN; DNA; MRE11 PROTEIN; S6 KINASE;

ARTICLE; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84890849140     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1306328110     Document Type: Article

References (47)

1. Agarwal S, Tafel AA, Kanaar R (2006) DNA double-Strand break repair and chromosome translocations. DNA Repair (Amst) 5(9-10):1075-1081.
2. Lee JH, Paull TT (2004) Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304(5667):93-96.
3. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15(17):2177-2196.
4. Kim ST, Lim DS, Canman CE, Kastan MB (1999) Substrate specificities and identification of putative substrates of ATMkinase familymembers. J Biol Chem274(53):37538-37543.
5. Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1(3):179-186.
6. Matsuoka S, et al. (2000) Ataxia telangiectasia-Mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97(19):10389-10394.
7. Hawley RS, Friend SH (1996) Strange bedfellows in even stranger places: The role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. Genes Dev 10(19):2383-2388.
8. Jackson SP (2001) Detecting, signalling and repairing DNA double-Strand breaks. Biochem Soc Trans 29(Pt 6):655-661.
9. Lavin MF (2007) ATM and the Mre11 complex combine to recognize and signal DNA double-Strand breaks. Oncogene 26(56):7749-7758.
10. Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW (1999) Identification of an extracellular signal-Regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274(5):2893-2898.
11. Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P (1998) Identification of regulatory phosphorylation sites in mitogen-Activated protein kinase (MAPK)-Activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem 273(3):1496-1505.
12. Sturgill TW, Ray LB, Erikson E, Maller JL (1988) Insulin-Stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334(6184):715-718.
13. Zhao Y, Bjørbaek C, Weremowicz S, Morton CC, Moller DE (1995) RSK3 encodes a novel pp90rsk isoform with a unique N-Terminal sequence: Growth factor-Stimulated kinase function and nuclear translocation. Mol Cell Biol 15(8):4353-4363.
14. Bunone G, Briand PA, Miksicek RJ, Picard D (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15(9):2174-2183.
15. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P (1998) Rsk-2 activity is necessary for epidermal growth factor-Induced phosphorylation of CREB protein and transcription of c-Fos gene. Proc Natl Acad Sci USA 95(21):12202-12207.
16. Grove JR, et al. (1993) Regulation of an epitope-Tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase. Biochemistry 32(30):7727-7738.
17. Ryves WJ, Evans AT, Olivier AR, Parker PJ, Evans FJ (1991) Activation of the PKC-Isotypes alpha, beta 1, gamma, delta and epsilon by phorbol esters of different biological activities. FEBS Lett 288(1-2):5-9.
18. Smith JA, et al. (2005) Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res 65(3): 1027-1034.
19. Clark DE, et al. (2005) The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res 65(8):3108-3116.
20. Xian W, et al. (2009) Fibroblast growth factor receptor 1-Transformed mammary epithelial cells are dependent on RSK activity for growth and survival. Cancer Res 69(6):2244-2251.
21. Kim J, et al. (2012) Rsk-Mediated phosphorylation and 14-3-3e binding of Apaf-1 suppresses cytochrome c-Induced apoptosis. EMBO J 31(5):1279-1292.
22. Lee YJ, et al. (2002) Protein kinase Cdelta overexpression enhances radiation sensitivity via extracellular regulated protein kinase 1/2 activation, abolishing the radiation-Induced G(2)-M arrest. Cell Growth Differ 13(5):237-246.
23. Warenius HM, et al. (2000) Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity. Br J Cancer 83(8):1084-1095.
24. Rinehart J, et al. (2004) Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-Small-Cell lung, breast, colon, and pancreatic cancer. J Clin Oncol 22(22):4456-4462.
25. Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-Activated protein kinase cascade to treat cancer. Nat Rev Cancer 4(12):937-947.
26. Sebolt-Leopold JS (2004) MEK inhibitors: A therapeutic approach to targeting the Ras-MAP kinase pathway in tumors. Curr Pharm Des 10(16):1907-1914.
27. Eisinger-Mathason TS, Andrade J, Lannigan DA (2010) RSK in tumorigenesis: Connections to steroid signaling. Steroids 75(3):191-202.
28. Sapkota GP, et al. (2007) BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem J 401(1):29-38.
29. Cohen MS, Zhang C, Shokat KM, Taunton J (2005) Structural bioinformatics-Based design of selective, irreversible kinase inhibitors. Science 308(5726):1318-1321.
30. Ray-David H, et al. (2013) RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance. Oncogene 32(38):4480-4489.
31. Li P, et al. (2012) P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation. Mol Biol Cell 23(8):1582-1592.
32. Di Virgilio M, Ying CY, Gautier J (2009) PIKK-Dependent phosphorylation of Mre11 induces MRN complex inactivation by disassembly from chromatin. DNA Repair (Amst) 8(11): 1311-1320.
33. Xu B, Kim ST, Lim DS, Kastan MB (2002) Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 22(4):1049-1059.
34. Zhou BB, et al. (2000) Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-Telangiectasia-Mutated kinase activity. J Biol Chem 275(14):10342-10348.
35. Wang Y, et al. (2012) Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutat Res 734(1-2):20-29.
36. Kumareswaran R, et al. (2012) Chronic hypoxia compromises repair of DNA doublestrand breaks to drive genetic instability. J Cell Sci 125(Pt 1):189-199.
37. Laval A, Kao J, Peters S (2007) ATM phosphorylation kinetics as a biological reporter of cellular radiosensitivity. Int J Radiat Oncol 69(3):S65-S66.
38. Wu JQ, et al. (2007) Control of Emi2 activity and stability through Mos-Mediated recruitment of PP2A. Proc Natl Acad Sci USA 104(42):16564-16569.
39. Guo Z, Deshpande R, Paull TT (2010) ATM activation in the presence of oxidative stress. Cell Cycle 9(24):4805-4811.
40. Buck M, Poli V, Hunter T, Chojkier M (2001) C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell 8(4):807-816.
41. Stracker TH, Theunissen JW, Morales M, Petrini JH (2004) The Mre11 complex and the metabolism of chromosome breaks: The importance of communicating and holding things together. DNA Repair (Amst) 3(8-9):845-854.
42. Paull TT, Gellert M (2000) A mechanistic basis for Mre11-Directed DNA joining at microhomologies. Proc Natl Acad Sci USA 97(12):6409-6414.
43. Löbrich M, Jeggo PA (2007) The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 7(11):861-869.
44. Jackson SP, Bartek J (2009) The DNA-Damage response in human biology and disease. Nature 461(7267):1071-1078.
45. Sakata K, Someya M, Matsumoto Y, HareyamaM(2007) Ability to repair DNAdouble-Strand breaks related to cancer susceptibility and radiosensitivity. Radiat Med 25(9):433-438.
46. Hurbin A, et al. (2005) Cooperation of amphiregulin and insulin-Like growth factor-1 inhibits Bax-And Bad-Mediated apoptosis via a protein kinase C-Dependent pathway in non-Small cell lung cancer cells. J Biol Chem 280(20):19757-19767.
47. Zhang L, Huang NJ, Chen C, Tang W, Kornbluth S (2012) Ubiquitylation of p53 by the APC/C inhibitor Trim39. Proc Natl Acad Sci USA 109(51):20931-20936.